Thomas Barnetche

7.0k total citations · 1 hit paper
124 papers, 4.6k citations indexed

About

Thomas Barnetche is a scholar working on Rheumatology, Immunology and Dermatology. According to data from OpenAlex, Thomas Barnetche has authored 124 papers receiving a total of 4.6k indexed citations (citations by other indexed papers that have themselves been cited), including 65 papers in Rheumatology, 45 papers in Immunology and 21 papers in Dermatology. Recurrent topics in Thomas Barnetche's work include Rheumatoid Arthritis Research and Therapies (44 papers), Spondyloarthritis Studies and Treatments (20 papers) and Systemic Lupus Erythematosus Research (19 papers). Thomas Barnetche is often cited by papers focused on Rheumatoid Arthritis Research and Therapies (44 papers), Spondyloarthritis Studies and Treatments (20 papers) and Systemic Lupus Erythematosus Research (19 papers). Thomas Barnetche collaborates with scholars based in France, United States and Switzerland. Thomas Barnetche's co-authors include Thierry Schaeverbeke, Marie‐Elise Truchetet, Bernard Combe, Jacques Morel, Marie Kostine, A Bertrand, Christophe Richez, C. Paul, L. Misery and C. Hua and has published in prestigious journals such as SHILAP Revista de lepidopterología, Scientific Reports and Human Molecular Genetics.

In The Last Decade

Thomas Barnetche

120 papers receiving 4.5k citations

Hit Papers

align trajectories

What are hit papers?

Hit papers significantly outperform the citation benchmark for their cohort. A paper qualifies if it has ≥500 total citations, achieves ≥1.5× the top-1% citation threshold for papers in the same subfield and year (this is the minimum needed to enter the top 1%, not the average within it), or reaches the top citation threshold in at least one of its specific research topics.

Immune related adverse events associated with anti-CTLA-4 antibodies: systematic review and meta-analysis

2015 540 citations Marie Kostine, Thomas Barnetche et al. profile →

Peers

Countries citing papers authored by Thomas Barnetche

Since Specialization

Citations

This map shows the geographic impact of Thomas Barnetche's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Thomas Barnetche with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Thomas Barnetche more than expected).

Fields of papers citing papers by Thomas Barnetche

Since Specialization

Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Thomas Barnetche. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Thomas Barnetche. The network helps show where Thomas Barnetche may publish in the future.

Co-authorship network of co-authors of Thomas Barnetche

This figure shows the co-authorship network connecting the top 25 collaborators of Thomas Barnetche. A scholar is included among the top collaborators of Thomas Barnetche based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Thomas Barnetche. Thomas Barnetche is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

Sort: Min cites: Since: Top N: Style:

20 of 20 papers shown

#	Work	Indexed citations
1	Comorbidity burden on mortality in patients with systemic sclerosis 2024 ·RMD Open ·(unknown), (unknown), (unknown), Julien Sénéschal, J. Constans, S. Skopinski, P. Duffau, Élodie Blanchard, Cécile Contin‐Bordes, Thomas Barnetche, Marie‐Elise Truchetet	2
2	POS1567 OUTCOMES AND PREDICTORS OF CHRONIC IMMUNE CHECKPOINT INHIBITOR INDUCED INFLAMMATORY ARTHRITIS: DATA FROM THE CANADIAN RESEARCH GROUP OF RHEUMATOLOGY IN IMMUNO-ONCOLOGY (CANRIO) RETROSPECTIVE COHORT 2023 ·Annals of the Rheumatic Diseases ·(unknown), (unknown), Shahin Jamal, Marie Hudson, Janet Pope, (unknown), J. Roberts, Dominic H. Moon, (unknown), Tatiana Nevskaya, E. Schmidt, (unknown), (unknown), Thomas Barnetche, Carrie Ye	0
3	Efficacy and Safety of Tumour Necrosis Factor-α Antagonists for Folliculitis Decalvans: A Retrospective Case-series Pilot Study 2023 ·Acta Dermato Venereologica ·(unknown), (unknown), B. Milpied, (unknown), (unknown), A.‐S. Darrigade, Thomas Barnetche, M.‐S. Doutre, (unknown), M. Beylot‐Barry, Julien Sénéschal	1
4	POS0970 PSYCHO-COGNITIVE FACTORS AND ADHERENCE IN AXIAL SPONDYLOARTHRITIS: A MULTICENTER CROSS-SECTIONAL STUDY 2023 ·Annals of the Rheumatic Diseases ·(unknown), Thomas Barnetche, (unknown), (unknown), Dana Jerome, (unknown), Cédric Lukas, Adeline Ruyssen‐Witrand, Anne Tournadre, Pascale Vergne‐Salle	1
5	Outcome of COVID-19 in patients with rheumatic and inflammatory diseases treated with mycophenolic acid: data from the French RMD COVID-19 cohort 2022 ·RMD Open ·Marie‐Elise Truchetet, Élodie Drumez, Thomas Barnetche, Claire Martin, Mathilde Devaux, Tiphaine Goulenok, (unknown), J. Schmidt, (unknown), Isabelle Melki, É. Hachulla, Christophe Richez	2
6	Analysis of tumor response and clinical factors associated with vitiligo in patients receiving anti–programmed cell death-1 therapies for melanoma: A cross-sectional study 2021 ·JAAD International ·L. Dousset, (unknown), Thomas Barnetche, Marie Kostine, Caroline Dutriaux, Anne Pham‐Ledard, M. Beylot‐Barry, E. Gérard, S. Prey, (unknown), Katia Boniface, Julien Sénéschal	15
7	Prognostic Role of Inflammasome Components in Human Colorectal Cancer 2020 ·Cancers ·Charlotte Domblides, Isabelle Soubeyran, Lydia Lartigue, (unknown), (unknown), Valérie Velasco, Thomas Barnetche, Patrick Blanco, Julie Déchanet‐Merville, Benjamin Faustin	10
8	Intestinal Inflammation in Children with Cystic Fibrosis Is Associated with Crohn’s-Like Microbiota Disturbances 2019 ·Journal of Clinical Medicine ·Raphaël Enaud, Katarzyna B. Hooks, Aurélien Barré, Thomas Barnetche, Christophe Hubert, (unknown), Thomas Bazin, (unknown), S. Bui, Michaël Fayon, Patrick Berger, Philippe Lehours, Cécile Bébéar, Macha Nikolski, Thierry Lamireau, Laurence Delhaès, Thierry Schaeverbeke	53
9	Predictive biological markers of systemic lupus erythematosus flares: a systematic literature review 2017 ·Arthritis Research & Therapy ·(unknown), Noémie Gensous, (unknown), Thomas Barnetche, Patrick Blanco, Estibaliz Lazaro, Julien Sénéschal, Marie‐Elise Truchetet, P. Duffau, Christophe Richez	61
10	Efficacy of Systemic Treatments of Psoriasis on Pruritus: A Systemic Literature Review and Meta-Analysis 2017 ·Journal of Investigative Dermatology ·(unknown), E. Brenaut, Thomas Barnetche, L. Misery	41
11	Rheumatic disorders associated with immune checkpoint inhibitors in patients with cancer—clinical aspects and relationship with tumour response: a single-centre prospective cohort study 2017 ·Annals of the Rheumatic Diseases ·Marie Kostine, L. Rouxel, Thomas Barnetche, Rémi Veillon, Florent Martin, Caroline Dutriaux, L. Dousset, Anne Pham‐Ledard, S. Prey, M. Beylot‐Barry, (unknown), Marine Gross‐Goupil, (unknown), Alain Ravaud, Édouard Forcade, B Bannwarth, Marie‐Elise Truchetet, Christophe Richez, Nadia Mehsen, Thierry Schaeverbeke	208
12	Abatacept monotherapy compared with abatacept plus disease-modifying anti-rheumatic drugs in rheumatoid arthritis patients: data from the ORA registry 2016 ·Arthritis Research & Therapy ·Marie‐Elise Truchetet, (unknown), Thomas Barnetche, (unknown), Jacques‐Eric Gottenberg, B Bannwarth, Christophe Richez, Thierry Schaeverbeke	10
13	Prevalence of undiagnosed psoriatic arthritis among psoriasis patients: Systematic review and meta-analysis 2015 ·Journal of the American Academy of Dermatology ·A. Villani, (unknown), M. Sevrain, Thomas Barnetche, C. Paul, M.‐A. Richard, M. Beylot‐Barry, L. Misery, P. Joly, Michel Le Maître, S. Aractingi, F. Aubin, Alain Cantagrel, Jean‐Paul Ortonne, D. Jullien	205
14	Alcohol consumption and psoriasis: a systematic literature review 2013 ·Journal of the European Academy of Dermatology and Venereology ·E. Brenaut, C. Horreau, Claire Pouplard, Thomas Barnetche, C. Paul, M.‐A. Richard, P. Joly, Michel Le Maître, S. Aractingi, F. Aubin, B. Cribier, D. Jullien, J.‐P. Ortonne, L. Misery	118
15	Cardiovascular morbidity and mortality in psoriasis and psoriatic arthritis: a systematic literature review 2013 ·Journal of the European Academy of Dermatology and Venereology ·C. Horreau, Claire Pouplard, E. Brenaut, Thomas Barnetche, L. Misery, B. Cribier, D. Jullien, S. Aractingi, F. Aubin, P. Joly, Michel Le Maître, J.‐P. Ortonne, C. Paul, M.‐A. Richard	243
16	Short-term Risk of Total Malignancy and Nonmelanoma Skin Cancers with Certolizumab and Golimumab in Patients with Rheumatoid Arthritis: Metaanalysis of Randomized Controlled Trials 2012 ·The Journal of Rheumatology ·(unknown), (unknown), Thomas Barnetche, Jacques Morel, Bernard Combe	30
17	The role of echocardiography in the assessment of right ventricular systolic function in patients with transposition of the great arteries and atrial redirection 2012 ·Archives of cardiovascular diseases ·Xavier Iriart, (unknown), Irene E. van Geldorp, Thomas Barnetche, Mathieu Léderlin, Maxime De Guillebon, Patricia Réant, Stéphane Lafitte, Jean‐Benoît Thambo	27
18	Incidence and risk of fatal myocardial infarction and stroke events in rheumatoid arthritis patients. A systematic review of the literature. 2009 ·PubMed ·L. Lévy, Bruno Fautrel, Thomas Barnetche, Thierry Schaeverbeke	91
19	New classification of HLA-DRB1alleles in rheumatoid arthritis susceptibility: a combined analysis of worldwide samples 2008 ·Arthritis Research & Therapy ·Thomas Barnetche, Arnaud Constantin, Alain Cantagrel, Anne Cambon‐Thomsen, Pierre‐Antoine Gourraud	31
20	Integration of microsatellite characteristics in the MHC region: a literature and sequence based analysis 2004 ·Tissue Antigens ·Pierre‐Antoine Gourraud, Shuhei Mano, Thomas Barnetche, Mary Carrington, Hidetoshi Inoko, Anne Cambon‐Thomsen	33

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact